Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/1/2025

Gastritis Causes and Complications

H. pylori-Associated Gastritis

  • H. pylori is the most important factor in the pathogenesis of chronic gastritis, present in 71-95% of all gastric cancer cases 1
  • H. pylori infection causes persistent active gastritis that may progress to atrophic gastritis, intestinal metaplasia, and eventually gastric cancer 4
  • The infection increases gastric cancer risk by approximately 2.5-fold, with some studies showing up to 6-fold increased risk 4
  • H. pylori eradication reduces the risk of gastric cancer development, especially when performed before the development of preneoplastic conditions 1
  • The pattern of gastritis caused by H. pylori can affect acid secretion - antral-predominant gastritis leads to increased acid production, while body-predominant gastritis causes decreased acid production 5

Autoimmune Gastritis

  • Autoimmune gastritis is the third major cause of gastritis, though significantly less common than H. pylori-associated gastritis 2, 3
  • Autoimmune gastritis has an estimated prevalence of 0.5-2% compared to up to 15% for all forms of atrophic gastritis 2, 3
  • It is characterized by autoantibodies against parietal cells and intrinsic factor 3
  • Autoimmune gastritis is more common in women and increases with age 3
  • It is strongly associated with other autoimmune diseases, particularly autoimmune thyroid diseases (Hashimoto's thyroiditis) 6
  • Pernicious anemia is a late-stage complication of autoimmune gastritis characterized by vitamin B-12 deficiency and macrocytic anemia 2

Clinical Implications and Complications

  • H. pylori gastritis can lead to peptic ulcer disease, atrophic gastritis, and gastric cancer 1, 7
  • Atrophic gastritis is considered the first step in a multistep precancerous cascade that can lead to gastric adenocarcinoma 2
  • The risk of progression from atrophic gastritis to gastric adenocarcinoma ranges from 0.1% to 0.3% per year 2
  • Corpus-predominant H. pylori gastritis substantially increases the risk for gastric cancer 1
  • Autoimmune gastritis increases the risk of type 1 gastric neuroendocrine tumors due to hypergastrinemia resulting from parietal cell loss 2
  • Patients with atrophic gastritis should be evaluated for iron and vitamin B-12 deficiencies, especially if corpus-predominant 8

Diagnostic Considerations

  • H. pylori infection can be diagnosed through non-invasive tests such as urea breath test and monoclonal stool antigen tests 5
  • In patients with autoimmune gastritis, testing for antiparietal cell antibodies and anti-intrinsic factor antibodies can assist with diagnosis 8
  • All individuals with atrophic gastritis should be assessed for H. pylori infection 8
  • Patients with unexplained iron or vitamin B-12 deficiency should be evaluated for atrophic gastritis 8